October 15, 2012
By Jim Moore
Potential passengers grounded by motion sickness may soon have a more effective medication to treat that queasy feeling. NASA has adapted a tried-and-true cure for delivery via nasal spray, a method that brings more rapid relief.
The space agency announced Oct. 12 a deal with Epiomed Therapeutics Inc., a California firm that aims to bring intranasal scopolamine (INSCOP, as NASA calls it) to the wider world.
"NASA and Epiomed will work closely together on further development of INSCOP to optimize therapeutic efficiency for both acute and chronic treatment of motion sickness which can be used by NASA, the Department of Defense and world travelers on land, in the air and on the seas," said Lakshmi Putcha, developer of the innovative treatment strategy at Johnson Space Center.
A nasal delivery produced promising results during tests at the Naval Aerospace Medical Research Laboratory in Pensacola, Fla., and the U.S. Navy is also working on an agreement to collaborate with Epiomed.
Clinical trials must still be conducted to secure approval from the Food and Drug Administration.
The management team running Chelton Flight Systems and S-Tec Corp. in Mineral Wells, Texas, for parent Cobham Avionics saw an opportunity and bought in.
Question: One of my friends is working to raise money for a charity. She wants to offer an airplane ride as a prize to one of the donors and has asked me to be the pilot in command. If am a private pilot, then how many hours of flight time would I need to have logged in order to act as pilot in command on this flight?
The European Aviation Safety Agency is making moves to reduce what the agency has called an "excessive" regulatory burden on general aviation.
VOLUNTEER AT AN AOPA FLY-IN NEAR YOU!
SHARE YOUR PASSION. VOLUNTEER AT AN AOPA FLY-IN. CLICK TO LEARN MORE >>>
VOLUNTEER LOCALLY AT AOPA FLY-IN! CLICK TO LEARN MORE >>>
BE A PART OF THE FLY-IN VOLUNTEER CREW! CLICK TO LEARN MORE >>>